Jury Awards $225K For Jaw Decay From Novartis Bone Drug

Law360, New York (April 9, 2012, 3:22 PM EDT) -- A federal jury in Missouri on Friday awarded $225,000 to a woman claiming Novartis Pharmaceuticals Corp.'s bone drug Zometa caused her mother's jaw disease, unanimously finding the drugmaker negligently failed to warn doctors about the drug's dangers.

After a little more than a day of deliberations, the jury told Novartis to pay compensatory damages to plaintiff Christine Winter but turned down her request for $7.5 million in punitive damages, according to Hollingsworth LLP, a firm representing Novartis.

John Beins, a Beins Goldberg & Hennessey LLP attorney...
To view the full article, register now.